E1210, a New Broad-Spectrum Antifungal, Suppresses Candida albicans Hyphal Growth through Inhibition of Glycosylphosphatidylinositol Biosynthesis
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Continued research toward the development of new antifungals that act via inhibition of glycosylphosphatidylinositol (GPI) biosynthesis led to the design of E1210. In this study, we assessed the selectivity of the inhibitory activity of E1210 against Candida albicans GWT1 (Orf19.6884) protein, Aspergillus fumigatus GWT1 (AFUA_1G14870) protein, and human PIG-W protein, which can catalyze the inositol acylation of GPI early in the GPI biosynthesis pathway, and then we assessed the effects of E1210 on key C. albicans virulence factors. E1210 inhibited the inositol acylation activity of C. albicans Gwt1p and A. fumigatus Gwt1p with 50% inhibitory concentrations (IC 50 s) of 0.3 to 0.6 μM but had no inhibitory activity against human Pig-Wp even at concentrations as high as 100 μM. To confirm the inhibition of fungal GPI biosynthesis, expression of ALS1 protein, a GPI-anchored protein, on the surfaces of C. albicans cells treated with E1210 was studied and shown to be significantly lower than that on untreated cells. However, the ALS1 protein levels in the crude extract and the RHO1 protein levels on the cell surface were found to be almost the same. Furthermore, E1210 inhibited germ tube formation, adherence to polystyrene surfaces, and biofilm formation of C. albicans at concentrations above its MIC. These results suggested that E1210 selectively inhibited inositol acylation of fungus-specific GPI which would be catalyzed by Gwt1p, leading to the inhibition of GPI-anchored protein maturation, and also that E1210 suppressed the expression of some important virulence factors of C. albicans , through its GPI biosynthesis inhibition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prodrug is metabolized by phosphatases and converted to manogepix (APX001A, formerly E1210) which inhibits the Gwt1 but not the human homolog Pig-W (Watanabe et al., 2012; Wiederhold et al., 2019).”
From Fungal Cell Wall: Emerging Antifungals and Drug Resistance. (2019) · cites this paper as Watanabe et al., 2012
In the citing paper
“MGX inhibits the conserved fungal glycosylphosphatidylinositol (GPI)-anchored wall transfer protein 1 (Gwt1) (13, 14).”
From Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial (2023) · cites this paper as [14]
In the citing paper
“There is limited information on the activity of this new class of antifungals, but in an early study manogepix inhibited C. albicans adherence and biofilm formation in a concentration dependent manner among other virulence factors [47].”
From Antifungal therapy of Candida biofilms: Past, present and future (2023) · cites this paper as [47]
In the citing paper
“E1210 is a broad-spectrum antifungal agent with a novel mechanism of action based on the inhibition of fungal glycosylphosphatidylinositol biosynthesis [144, 145].”
From Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents (2013) · cites this paper as [144]
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K., & Marr, K. (2009) · Clinical Infectious Diseases · doi:10.1086/595846 · Cited by 801 · cited 1×
“The incidence of life-threatening fungal infections has increased steadily over the past 2 decades as a result of an increase in the number of susceptible immunosuppressed patients (39, 68).”
BackgroundLee, K. L., Buckley, H. R., & Campbell, C. C. (1975) · Medical Mycology · doi:10.1080/00362177585190271 · Cited by 788 · cited 1×
“5% glucose (YNB), Spider medium (31), Lee’s medium (28), YPD broth (Becton Dickinson Company) supplemented with 10% fetal calf serum (FCS), and yeast nitrogen base without amino acids but supplemented with 2.”
MethodSuppression of Hyphal Formation in Candida albicans by Mutation of a STE12 Homolog
Liu, H., Köhler, J., & Fink, G. R. (1994) · Science · doi:10.1126/science.7992058 · Cited by 786 · cited 1×
“5% glucose (YNB), Spider medium (31), Lee’s medium (28), YPD broth (Becton Dickinson Company) supplemented with 10% fetal calf serum (FCS), and yeast nitrogen base without amino acids but supplemented with 2.”
MethodStandardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718 · cited 1×
“Resistance is also becoming an increasing problem, particularly among members of the azole class (33, 44, 45, 47, 66).”
BackgroundRamage, G., Saville, S. P., Thomas, D. P., & López-Ribot, J. L. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.633-638.2005 · Cited by 678 · cited 2×
“albicans have each been reported to be associated with biofilm formation (3, 41, 49).”
BackgroundMethodArchitecture of the Yeast Cell Wall
Kollár, R., Reinhold, B. B., Petráková, E., Yeh, H. J. C., Ashwell, G., Drgonová, J., Kapteyn, J. C., Klis, F. M., & Cabib, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17762 · Cited by 644 · cited 1×
“synthesis and assembly are GPI anchored, and GPI synthesis and/or anchoring is essential for cell viability in yeasts (27, 29, 43, 46).”
BackgroundThe ALS gene family of Candida albicans.
Hoyer, L. L. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)01984-9 · Cited by 540 · cited 1×
“Examples of GPI-anchored virulence factors are the Als protein family, adhesins with broad substrate specificity (15, 23, 55); Hwp1p, an epithelial adhesin and biofilm promoter (40); Eap1p, an adhesin to epithelial cells and polystyrene surfaces (30); secreted aspartyl proteinases Sap9p and Sap10p, phospholipase B Plb…”
BackgroundCandida albicans Cell Wall Proteins
Chaffin, W. L. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00032-07 · Cited by 515 · cited 4×
“The yeast-to-hypha transition inhibition by E1210 seems to occur as the result not of signal transduction inhibition but of the maturation inhibition of GPI-anchored proteins involved in cell wall assembly, such as via exo-1,3-glucanase (Exg2 and Spr1), -1,6-glucan synthase (Kre1), transglycosidase (Crh1), -1,3- gluca…”
BackgroundInfluentialPeter, O., & Menon, A. K. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r700002-jlr200 · Cited by 403
Function of Candida albicans Adhesin Hwp1 in Biofilm Formation
Nobile, C. J., Nett, J. E., Andes, D. R., & Mitchell, A. P. (2006) · Eukaryotic Cell · doi:10.1128/ec.00194-06 · Cited by 395 · cited 1×
“Examples of GPI-anchored virulence factors are the Als protein family, adhesins with broad substrate specificity (15, 23, 55); Hwp1p, an epithelial adhesin and biofilm promoter (40); Eap1p, an adhesin to epithelial cells and polystyrene surfaces (30); secreted aspartyl proteinases Sap9p and Sap10p, phospholipase B Plb…”
BackgroundAndes, D., Nett, J., Oschel, P., Albrecht, R., Marchillo, K., & Pitula, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.6023-6031.2004 · Cited by 389 · cited 1×
“albicans have each been reported to be associated with biofilm formation (3, 41, 49).”
BackgroundMultiple-Triazole–Resistant Aspergillosis
Verweij, P. E., Mellado, E., & Melchers, W. J. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmc061720 · Cited by 380
Complementary Adhesin Function in C. albicans Biofilm Formation
Nobile, C. J., Schneider, H. A., Nett, J. E., Sheppard, D. C., Filler, S. G., Andes, D. R., & Mitchell, A. P. (2008) · Current Biology · doi:10.1016/j.cub.2008.06.034 · Cited by 351 · cited 1×
“albicans have each been reported to be associated with biofilm formation (3, 41, 49).”
BackgroundThe cell wall architecture of Candida albicans wild‐type cells and cell wall‐defective mutants
Kapteyn, J. C., Hoyer, L. L., Hecht, J. E., Müller, W. H., Andel, A., Verkleij, A. J., Makarow, M., Van Den Ende, H., & Klis, F. M. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01729.x · Cited by 328
Therapy for fungal diseases: opportunities and priorities
Denning, D. W., & Hope, W. W. (2010) · Trends in Microbiology · doi:10.1016/j.tim.2010.02.004 · Cited by 314 · cited 1×
“Drugs available for human invasive fungal infections are represented principally by four classes of compounds—polyenes, fluorinated pyrimidines, azoles, and echinocandins— but they each have limited usefulness because of their limited spectrum of antifungal activity, adverse effects, drug-drug interactions, variable p…”
BackgroundFunctional and Structural Diversity in the Als Protein Family of Candida albicans
Sheppard, D. C., Yeaman, M. R., Welch, W. H., Phan, Q. T., Fu, Y., Ibrahim, A. S., Filler, S. G., Zhang, M., Waring, A. J., & Edwards, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401929200 · Cited by 300 · cited 2×
“albicans (15, 55), GPI biosynthesis inhibition is expected to lead to the suppression of hyphal growth and reduce adherence of C.”
BackgroundMartchenko, M., Alarco, A.-M., Harcus, D., & Whiteway, M. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-03-0179 · Cited by 290 · cited 1×
“Examples of GPI-anchored virulence factors are the Als protein family, adhesins with broad substrate specificity (15, 23, 55); Hwp1p, an epithelial adhesin and biofilm promoter (40); Eap1p, an adhesin to epithelial cells and polystyrene surfaces (30); secreted aspartyl proteinases Sap9p and Sap10p, phospholipase B Plb…”
BackgroundIn Vitro Activity of Caspofungin against Candida albicans Biofilms
Bachmann, S. P., VandeWalle, K., Ramage, G., Patterson, T. F., Wickes, B. L., Graybill, J. R., & López-Ribot, J. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3591-3596.2002 · Cited by 288
Albrecht, A., Felk, A., Pichova, I., Naglik, J. R., Schaller, M., de Groot, P., MacCallum, D., Odds, F. C., Schäfer, W., Klis, F., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509297200 · Cited by 270 · cited 1×
“Examples of GPI-anchored virulence factors are the Als protein family, adhesins with broad substrate specificity (15, 23, 55); Hwp1p, an epithelial adhesin and biofilm promoter (40); Eap1p, an adhesin to epithelial cells and polystyrene surfaces (30); secreted aspartyl proteinases Sap9p and Sap10p, phospholipase B Plb…”
BackgroundBrown Jr, D. H., Giusani, A. D., Chen, X., & Kumamoto, C. A. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01619.x · Cited by 262 · cited 1×
“albicans cells embedded within a matrix promoted the formation of hyphae (6), the morphology of cells growing in colonies in YPS agar medium was studied.”
BackgroundGenome-Wide Fitness Test and Mechanism-of-Action Studies of Inhibitory Compounds in Candida albicans
Xu, D., Jiang, B., Ketela, T., Lemieux, S., Veillette, K., Martel, N., Davison, J., Sillaots, S., Trosok, S., Bachewich, C., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030092 · Cited by 254 · cited 1×
“albicans (69), Gwt1p was not a target of the existing antifungal compounds.”
BackgroundBiosynthesis and function of GPI proteins in the yeast Saccharomyces cerevisiae
Pittet, M., & Conzelmann, A. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.05.015 · Cited by 251 · cited 1×
“synthesis and assembly are GPI anchored, and GPI synthesis and/or anchoring is essential for cell viability in yeasts (27, 29, 43, 46).”
BackgroundSeidler, M. J., Salvenmoser, S., & Müller, F.-M. C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00234-08 · Cited by 229 · cited 1×
“Safranin is capable of staining exopolymeric material structures (53, 54); therefore, biofilm formation was evaluated by determining the biofilm density after safranin staining.”
MethodTrends in the Epidemiology of Invasive Fungal Infections
Warnock, D. W. (2007) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.48.1 · Cited by 226 · cited 1×
“The incidence of life-threatening fungal infections has increased steadily over the past 2 decades as a result of an increase in the number of susceptible immunosuppressed patients (39, 68).”
BackgroundCandida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway
Fu, Y., Ibrahim, A. S., Sheppard, D. C., Chen, Y., French, S. W., Cutler, J. E., Filler, S. G., & Edwards, J. E. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02873.x · Cited by 218 · cited 4×
“albicans (15, 55), GPI biosynthesis inhibition is expected to lead to the suppression of hyphal growth and reduce adherence of C.”
BackgroundInfluentialIn Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds
Miyazaki, M., Horii, T., Hata, K., Watanabe, N.-A., Nakamoto, K., Tanaka, K., Shirotori, S., Murai, N., Inoue, S., Matsukura, M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00291-11 · Cited by 200
Self-citationDavis, D. A., Bruno, V. M., Loza, L., Filler, S. G., & Mitchell, A. P. (2002) · Genetics · doi:10.1093/genetics/162.4.1573 · Cited by 184
Leidich, S. D., Drapp, D. A., & Orlean, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34042-5 · Cited by 178
Critical roles of glycosylphosphatidylinositol for Trypanosoma brucei
Nagamune, K., Nozaki, T., Maeda, Y., Ohishi, K., Fukuma, T., Hara, T., Schwarz, R. T., Sütterlin, C., Brun, R., Riezman, H., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180230697 · Cited by 173
Messer, S. A., Jones, R. N., & Fritsche, T. R. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1782-1787.2006 · Cited by 172
Comprehensive Analysis of Glycosylphosphatidylinositol-Anchored Proteins in Candida albicans
Richard, M. L., & Plaine, A. (2007) · Eukaryotic Cell · doi:10.1128/ec.00297-06 · Cited by 159 · cited 3×
“The yeast-to-hypha transition inhibition by E1210 seems to occur as the result not of signal transduction inhibition but of the maturation inhibition of GPI-anchored proteins involved in cell wall assembly, such as via exo-1,3-glucanase (Exg2 and Spr1), -1,6-glucan synthase (Kre1), transglycosidase (Crh1), -1,3- gluca…”
BackgroundTronchin, G., Bouchara, J. P., Robert, R., & Senet, J. M. (1988) · Infection and Immunity · doi:10.1128/iai.56.8.1987-1993.1988 · Cited by 152 · cited 1×
“albicans germ tubes adhere to plastic surfaces (1, 62).”
BackgroundHata, K., Horii, T., Miyazaki, M., Watanabe, N.-A., Okubo, M., Sonoda, J., Nakamoto, K., Tanaka, K., Shirotori, S., Murai, N., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00366-11 · Cited by 149 · cited 2×
“We have modified the prototype compound BIQ (38, 59, 63) and developed E1210, which possesses potent antifungal activity (19, 34).”
BackgroundMethodSelf-citationEap1p, an Adhesin That Mediates Candida albicans Biofilm Formation In Vitro and In Vivo
Li, F., Svarovsky, M. J., Karlsson, A. J., Wagner, J. P., Marchillo, K., Oshel, P., Andes, D., & Palecek, S. P. (2007) · Eukaryotic Cell · doi:10.1128/ec.00049-07 · Cited by 148
The GPI biosynthetic pathway as a therapeutic target for African sleeping sickness
Ferguson, M. A. J., Brimacombe, J. S., Brown, J. R.-M., Crossman, A., Dix, A. P., Field, R. A., Güther, M. L. S., Milne, K. G., Sharma, D. K., & Smith, T. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00058-7 · Cited by 143
Mosel, D. D., Dumitru, R., Hornby, J. M., Atkin, A. L., & Nickerson, K. W. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.8.4938-4940.2005 · Cited by 140 · cited 4×
“5 mM N-acetylglucosamine (35) were also used.”
InfluentialHong, Y., Maeda, Y., Watanabe, R., Ohishi, K., Mishkind, M., Riezman, H., & Kinoshita, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35099 · Cited by 135 · cited 1×
“YW3548, a natural product, is thought to inhibit the addition of phosphoethanolamine (EtNP) to the first mannose of GPI, but it inhibits both yeast and mammalian GPI-EtNP transferases, although EtNP modification of the first mannose is not essential for the surface expression of GPI-anchored proteins on mammalian cell…”
BackgroundGWT1 Gene Is Required for Inositol Acylation of Glycosylphosphatidylinositol Anchors in Yeast
Umemura, M., Okamoto, M., Nakayama, K.-I., Sagane, K., Tsukahara, K., Hata, K., & Jigami, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301044200 · Cited by 127 · cited 2×
“In the course of screening compounds that inhibit the cell wall assembly of GPI-anchored proteins, we discovered the GWT1 gene (63), which encodes an inositol acyltransferase found early in the GPI biosynthesis pathway (36, 64), and this led to the creation of an inhibitor of this enzyme, 1-(4-butylbenzyl)isoquinoline…”
BackgroundSelf-citationPfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00535-08 · Cited by 120 · cited 1×
“Resistance is also becoming an increasing problem, particularly among members of the azole class (33, 44, 45, 47, 66).”
BackgroundTsukahara, K., Hata, K., Nakamoto, K., Sagane, K., Watanabe, N., Kuromitsu, J., Kai, J., Tsuchiya, M., Ohba, F., Jigami, Y., et al. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03481.x · Cited by 118 · cited 10×
“BIQ, a prototype Gwt1p inhibitor, also reduced the adherence of C. albicans to epithelial cells (63).”
BackgroundMethodInfluentialSelf-citationPIG-W Is Critical for Inositol Acylation but Not for Flipping of Glycosylphosphatidylinositol-Anchor
Murakami, Y., Siripanyapinyo, U., Hong, Y., Kang, J. Y., Ishihara, S., Nakakuma, H., Maeda, Y., & Kinoshita, T. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-03-0193 · Cited by 110 · cited 2×
“In the course of screening compounds that inhibit the cell wall assembly of GPI-anchored proteins, we discovered the GWT1 gene (63), which encodes an inositol acyltransferase found early in the GPI biosynthesis pathway (36, 64), and this led to the creation of an inhibitor of this enzyme, 1-(4-butylbenzyl)isoquinoline…”
BackgroundTheiss, S., Ishdorj, G., Brenot, A., Kretschmar, M., Lan, C.-Y., Nichterlein, T., Hacker, J., Nigam, S., Agabian, N., & Köhler, G. A. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2006.03.003 · Cited by 107 · cited 1×
“Examples of GPI-anchored virulence factors are the Als protein family, adhesins with broad substrate specificity (15, 23, 55); Hwp1p, an epithelial adhesin and biofilm promoter (40); Eap1p, an adhesin to epithelial cells and polystyrene surfaces (30); secreted aspartyl proteinases Sap9p and Sap10p, phospholipase B Plb…”
BackgroundIdentification of a species‐specific inhibitor of glycosylphosphatidylinositol synthesis
Sütterlin, C., Horváth, A., Gerold, P., Schwarz, R. Τ., Wang, Y., Dreyfuss, M., & Riezman, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6374 · Cited by 101 · cited 1×
“YW3548, a natural product, is thought to inhibit the addition of phosphoethanolamine (EtNP) to the first mannose of GPI, but it inhibits both yeast and mammalian GPI-EtNP transferases, although EtNP modification of the first mannose is not essential for the surface expression of GPI-anchored proteins on mammalian cell…”
BackgroundCostello, L. C., & Orlean, P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42485-4 · Cited by 100 · cited 1×
“matography plates were developed in CHCl3-CH3OH-H2O (65:25:4, vol/ vol/vol) (10).”
Richard, M., Ibata‐Ombetta, S., Dromer, F., Bordon‐Pallier, F., Jouault, T., & Gaillardin, C. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02926.x · Cited by 81 · cited 1×
“The GPI7-null mutant showed reduced hyphal growth on solid media, increased sensitivity to Calcofluor white (CFW), reduced virulence in mice, and lytic action of macrophages (50).”
BackgroundToenjes, K. A., Munsee, S. M., Ibrahim, A. S., Jeffrey, R., Edwards, J. E., & Johnson, D. I. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.963-972.2005 · Cited by 72
Seidler, M. J., Salvenmoser, S., & Müller, F. C. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.07.024 · Cited by 71
Identification of Candida albicans exposed surface proteins in vivo by a rapid proteomic approach
Hernáez, M. L., Ximénez‐Embún, P., Martínez-Gomáriz, M., Gutiérrez, D., Nombela, C., & Gil, C. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.02.008 · Cited by 68 · cited 1×
“albicans; however, non-GPI-anchored proteins are also virulence factors (21).”
BackgroundGene Overexpression/Suppression Analysis of Candidate Virulence Factors of Candida albicans
Fu, Y., Luo, G., Spellberg, B. J., Edwards, J. E., & Ibrahim, A. S. (2008) · Eukaryotic Cell · doi:10.1128/ec.00445-07 · Cited by 65 · cited 1×
“albicans include proteins which mediate adherence to and invasion of host tissues, morphological changes from yeast to hyphae, secretion of lytic enzymes, maintenance of cell wall integrity, and avoidance of the host immune response (16).”
BackgroundPresterl, E., Daxböck, F., Graninger, W. B., & Willinger, B. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01812.x · Cited by 63
Epp, E., Walther, A., Lépine, G., Leon, Z., Mullick, A., Raymond, M., Wendland, J., & Whiteway, M. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.07038.x · Cited by 53 · cited 1×
“In addition, from a large-scale survey of homozygously null mutants, GPI8 was suggested to be essential (11), whereas a null mutant of GPI11 was viable (13), although both orthologous genes of S.”
BackgroundAbe, S., Satoh, T., Tokuda, Y., Tansho, S., & Yamaguchi, H. (1994) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1994.tb01795.x · Cited by 53 · cited 2×
“determined using the crystal violet staining assay (1).”
BackgroundMethodInhibitors of glycosyl-phosphatidylinositol anchor biosynthesis
de Macedo, C. S., Shams-Eldin, H., Smith, T., Schwarz, R. Τ., & Azzouz, N. (2003) · Biochimie · doi:10.1016/s0300-9084(03)00065-8 · Cited by 51
Synthesis and evaluation of novel antifungal agents-quinoline and pyridine amide derivatives
Nakamoto, K., TSUKADA, I., Tanaka, K., Matsukura, M., Haneda, T., Inoue, S., Murai, N., Abe, S., Ueda, N., Miyazaki, M., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.005 · Cited by 49 · cited 5×
“BIQ, a prototype Gwt1p inhibitor, also reduced the adherence of C. albicans to epithelial cells (63).”
MethodInfluentialSelf-citationHashash, R., Younes, S., Bahnan, W., El Koussa, J., Maalouf, K., Dimassi, H. I., & Khalaf, R. A. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01883.x · Cited by 37 · cited 1×
“The PGA1 mutant showed reduced adherence and biofilm formation and increased sensitivity to CFW but increased filamentation (18).”
BackgroundGrimme, S. J. (2004) · Microbiology · doi:10.1099/mic.0.27254-0 · Cited by 37 · cited 1×
“Although there is a GPI core structure (ethanolamineP-6Man 1-2Man 1-6Man 1-4GlcNH2 1-6-D-myo-inositol1-phosphate-lipid, where the lipid is either diacylglycerol, acylalkylglycerol, or ceramide) which is conserved in all eukaryotes (26), many subtle but significant differences that can occur as the result of additional…”
BackgroundThe Candida albicans homologue of PIG-P, CaGpi19p: gene dosage and role in growth and filamentation
Victoria, G. S., Kumar, P., & Komath, S. S. (2010) · Microbiology · doi:10.1099/mic.0.039628-0 · Cited by 33 · cited 1×
“The conditional null mutation of GPI19 led to reduced surface GPI anchor levels, cell wall biogenesis aberrations (aggregation), and increased filamentation, but not increased CFW sensitivity (67).”
BackgroundWout, J. W. V., Meynaar, I. A., Linde, I., Poell, R., Mattie, H., & van Furth, R. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.5.803 · Cited by 27 · cited 1×
“Although others have reported that azole antifungals can inhibit germ tube formation (20, 65), our observations were more consistent with those of Brayman and Wilks (5).”
ResultBrayman, T. G., & Wilks, J. W. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3305-3310.2003 · Cited by 23
Smith, T. K., Kimmel, J., Azzouz, N., Shams-Eldin, H., & Schwarz, R. Τ. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703784200 · Cited by 22 · cited 1×
“Serine protease inhibitors such as phenylmethylsulfonyl fluoride (PMSF) and diisopropyl fluoride inhibit ethanolamine phosphate addition and inositol acylation of GPI in Toxoplasma gondii and Trypanosoma brucei, which are suggested to have an activated serine that is absent in the other orthologues (56).”
BackgroundIn Vitro Activity of Micafungin against Planktonic and Sessile Candida albicans Isolates
Jacobson, M. J., Steckelberg, K. E., Piper, K. E., Steckelberg, J. M., & Patel, R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01724-08 · Cited by 22
The effects of antifungal agents on the morphogenetic transformation by Candida albicans in vitro
Hawser, S., Francolini, M., & Islam, K. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.4.579 · Cited by 18 · cited 2×
“Although others have reported that azole antifungals can inhibit germ tube formation (20, 65), our observations were more consistent with those of Brayman and Wilks (5).”
ResultTanaka, K., Inoue, S., Murai, N., Shirotori, S., Nakamoto, K., Abe, S., Horii, T., Miyazaki, M., Hata, K., Watanabe, N., et al. (2010) · Chemistry Letters · doi:10.1246/cl.2010.1033 · Cited by 15 · cited 5×
“BIQ, a prototype Gwt1p inhibitor, also reduced the adherence of C. albicans to epithelial cells (63).”
MethodInfluentialSelf-citationMPR1 as a novel selection marker in Saccharomyces cerevisiae
Ogawa‐Mitsuhashi, K., Sagane, K., Kuromitsu, J., Takagi, H., & Tsukahara, K. (2009) · Yeast · doi:10.1002/yea.1708 · Cited by 11 · cited 1×
“CaGWT1 was inserted into the multiple-copy plasmid YEp352GAPII and the single-copy plasmid pRS316 (42), and the resultant newly constructed plasmids were designated YEp-Ca and pRSCa, respectively.”
MethodSelf-citationGlycosylphosphatidylinositol (GPI) Anchoring of Proteins
(2009) · The Enzymes · doi:10.1016/c2009-0-01892-3 · Cited by 9
Research works printed but not linked: 3
- Clinical Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard-third edition M27–A3. Clinical and Laboratory Standards Institute Wayne PA.
- SmithTK. 2009. Inhibitors of GPI biosynthesis, P. 247–267. In MenonAK KinoshitaT OrleanP TamanoiF (ed.), The enzymes, vol. XXVI. Glycosylphosphatidylinositol (GPI) anchoring of proteins, Academic Press, London, United Kingdom.
- Yoko-oT JigamiY. 2009. Inositol acylation/deacylation, p. 65–90. In MenonAK KinoshitaT OrleanP TamanoiF (ed.), The enzymes, vol. XXVI. Glycosylphosphatidylinositol (GPI) anchoring of proteins. Academic Press, London, United Kingdom.
Cited by
Candida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
The antifungal pipeline: a reality check
Perfect, J. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.46 · Cited by 866
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Hoenigl, M., Sprute, R., Egger, M., Arastehfar, A., Cornely, O. A., Krause, R., Lass-Flörl, C., Prattes, J., Spec, A., Thompson, G. R., et al. (2021) · Drugs · doi:10.1007/s40265-021-01611-0 · Cited by 467
“The action of manogepix appears to be fungal pathogen specific, as it does not inhibit human inositol acylation by the closest mammalian ortholog, PIGW [64, 72].”
BackgroundSpampinato, C., & Leonardi, D. (2013) · BioMed Research International · doi:10.1155/2013/204237 · Cited by 411
“E1210 is a broad-spectrum antifungal agent with a novel mechanism of action based on the inhibition of fungal glycosylphosphatidylinositol biosynthesis [144, 145].”
BackgroundKinoshita, T., & Fujita, M. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r063313 · Cited by 273
“Importantly, the compound seems to be fungal specific and does not inhibit mammalian GPI inositol acylase PIG-W activity (194).”
Background
Metadata
- Authors
- Watanabe, N.-A., Miyazaki, M., Horii, T., Sagane, K., Tsukahara, K., & Hata, K.
- Affiliations
- Next Generation Systems Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd., Tsukuba, Ibaraki, Japan
- Eisai (Japan) (JP)
- ORCID
- Sagane, Koji
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2012-02
- Volume
- 56
- Issue
- 2
- Pages
- 960-971
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3264227
- OpenAlex
- W1987354838
- Cited by
- 169
- References
- 67
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 20 · 2023: 14 · 2022: 14 · 2021: 11 · 2020: 14 · 2019: 15 · 2018: 12 · 2017: 14 · 2016: 6 · 2015: 6 · 2014: 7 · 2013: 5 · 2012: 2
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- antifungal agents, Candida albicans, Aspergillus fumigatus, glycosylphosphatidylinositol biosynthesis, virulence factors, germ tube formation, biofilm formation, ALS1, Rho1
- MeSH terms
- Acylation, Aminopyridines, Antifungal Agents, Candida albicans, Candidiasis, Fungal Proteins, Humans, Inositol, Isoxazoles, Virulence, Gene Expression Regulation, Fungal, Glycosylphosphatidylinositols, Hyphae, Virulence Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.